Risks, limitations, and responsible use of AISN technologies
The AISN project develops AI-based systems to support clinicians in decision-making and to optimise personalised stroke rehabilitation pathways. While these technologies offer important benefits, it is essential to clearly communicate their limitations and potential risks to patients, carers, clinicians, and other stakeholders.
Technical and clinical limitations
AI systems used in AISN rely on data-driven models to support clinical decision-making and rehabilitation planning. These systems have inherent limitations:
- Dependence on data quality and representativeness: The performance of AI systems depends on the data used for training and validation. Limited or biased datasets may affect the accuracy and fairness of recommendations.
- Uncertainty in the outputs: AI outputs are probabilistic and may not always be accurate, particularly in complex or atypical patient cases.
- Generalisation limits: Models developed in specific clinical contexts may not perform equally well across different healthcare settings or populations.
- Evolving system performance: AI systems may be updated over time, which can lead to changes in outputs and require continuous validation and monitoring.
For these reasons, AISN tools are intended to support clinical judgement, not replace it.
The integration of AI-based recommendations into clinical workflows introduces several risks:
- Over-reliance on AI outputs by clinicians or patients
- Misinterpretation of recommendations, especially without sufficient explanation or context
- Potential inaccuracies, which could impact treatment planning if not properly assessed
- Variability in patient response, to rehabilitation, as outcomes may differ between individuals
- Accessibility and usability challenges, particularly for patients with different levels of digital literacy
AISN mitigates these risks through clinical validation, iterative testing, and involvement of healthcare professionals and patients in system design and evaluation.
AISN is developed in line with European ethical principles for trustworthy AI, ensuring respect for fundamental rights, patient safety, and human dignity. Key ethical considerations include:
- Human oversight and responsibility: AI systems support, but do not replace, healthcare professionals. Final decisions remain under the responsibility of qualified clinicians.
- Patient autonomy and informed participation: Patients and carers should be informed about the role of AI in their care and be able to ask questions and express preferences.
- Fairness and non-discrimination: Efforts are made to identify and reduce biases in data and algorithms to avoid unequal outcomes across different population groups.
- Transparency and explainability: AISN promotes clear communication about how AI systems work, their purpose, and their limitations.
- Safety and risk management: Continuous monitoring, validation, and evaluation are carried out to ensure safe system performance.
These principles reflect the project’s commitment to ensuring that AI is developed and used in a way that benefits patients while minimising harm.
AISN operates in compliance with applicable European and national regulations governing data protection, medical research, and digital health technologies:
- Data protection (GDPR): Personal data is processed securely, with appropriate safeguards to ensure confidentiality and privacy.
- Data governance and access control: Access to data is restricted to authorised users, and data handling follows strict protocols.
- Regulatory compliance: AISN aligns with relevant frameworks for medical devices and AI systems in healthcare.
- Accountability and traceability: System use and outputs are documented to support auditability and responsibility.
These measures ensure that patient data is protected and that the use of AI complies with legal and regulatory standards.
To ensure that AISN technologies are used safely and effectively, the following measures are implemented:
- Clinical validation and continuous evaluation of system performance
- User-centred design, involving clinicians and patients in development and testing
- Training and guidance for healthcare professionals using the system
- Clear communication materials for patients and carers
- Defined roles and responsibilities, ensuring human oversight at all stages
AI outputs must always be interpreted within the broader clinical context, taking into account professional expertise and individual patient needs.
A key objective of AISN is to ensure that patients, carers, and stakeholders are clearly informed about both the benefits and limitations of AI technologies:
- Information is provided through the AISN website and supporting materials
- Content is designed to be accessible and understandable for non-expert audiences
- Risks and limitations are communicated in a transparent and balanced way
- Stakeholders are encouraged to engage with the information and seek clarification where needed
This approach supports informed decision-making and helps build trust in the responsible use of AI in stroke rehabilitation.
AISN brings together different AI-based tools to support stroke rehabilitation, from assisting healthcare professionals in decision-making to enabling more personalised care across the recovery pathway. While these technologies can enhance care, it is important to understand their scope, limitations, and how they should be used responsibly.
The table below summarises the main types of AISN technologies described on the website and the key limitations and safe-use messages that patients and carers should be aware of. These examples are intended to support understanding, not to provide individual medical advice.
|
AISN technology or tool
|
What it supports
|
Main limitations
|
Safe-use message for patients and carers
|
|
AI-based clinical decision-support and prediction tools
|
Support healthcare professionals in analysing patient data, predicting recovery pathways, and selecting rehabilitation strategies
|
Outputs depend on the quality and completeness of available data; predictions may be uncertain and may not apply equally to every patient
|
These tools support clinical judgement but do not replace healthcare professionals
|
|
BrainX3 / brain simulation tools
|
Help explain and model aspects of brain function and recovery relevant to stroke rehabilitation
|
Simulations are simplified models and cannot provide certain predictions about an individual patient’s recovery
|
Simulation outputs should be interpreted by qualified professionals and used as one source of information
|
|
Rehabilitation Gaming System / digital rehabilitation tools
|
Support rehabilitation exercises and more personalised rehabilitation in clinical or home settings
|
Not every tool will be suitable for every patient; usability, access, fatigue, motivation, or individual response may vary
|
Use should be guided by healthcare professionals and adapted to the patient’s abilities and needs
|
|
AI-supported communication and information tools
|
Help improve how information is shared between healthcare professionals, patients, and carers
|
Information may need explanation, and patients may differ in how they understand or prefer to receive it
|
Patients and carers should be encouraged to ask questions and discuss unclear information with their care team
|
Understanding the limitations
AI systems in AISN support clinical care and decision-making, and are intended to be used with appropriate awareness of their scope and limitations.
- Their performance depends on the quality and completeness of available data
- Recommendations and predictions may not always apply equally to every patient
- Results may vary depending on the clinical setting and individual circumstances
- Some AI outputs may be complex and require professional interpretation
- System performance may evolve over time as technologies are refined
Possible risks
The use of AI technologies in healthcare requires careful consideration of potential risks:
- Over-reliance on AI outputs without appropriate clinical judgement
- Misinterpretation of recommendations if not properly explained
- Incomplete or uncertain outputs in some situations
- Differences in how patients respond to rehabilitation approaches
- Barriers to access or use, including differences in digital skills
- These risks are addressed in AISN through clinical validation, continuous evaluation, and close involvement of healthcare professionals and patients.
Safety, ethics, and data protection
AISN follows European principles for trustworthy AI and healthcare:
- Personal data is protected in line with data protection regulations (GDPR)
- Patients are informed about how AI supports their care
- Systems are designed to promote fairness and reduce bias
- Healthcare professionals remain fully responsible for medical decisions
Responsible use
To ensure safe and effective use of AISN technologies:
- AI outputs should always be reviewed and interpreted by qualified healthcare professionals
- Patients and carers are encouraged to ask questions and understand how AI is used
- Treatment decisions should combine medical expertise, AI support, and patient preferences
Understanding how these technologies work, and their appropriate use, helps ensure that AI is applied in a way that is safe, transparent, and beneficial for patients.
FAQ
What does AISN use AI for?
AISN uses AI to support healthcare professionals in planning and personalising stroke rehabilitation and improving patient care.
Can AI make decisions about my treatment?
No. AI provides support and recommendations, but healthcare professionals always make the final decisions.
Are AI recommendations always correct?
AI supports decision-making, but its results may vary depending on the data available and individual patient situations.
Is my personal data safe?
Yes. AISN follows strict European data protection rules (GDPR) to ensure your data is secure and used responsibly.
What are the main risks of using AI in rehabilitation?
Risks include misinterpretation of results, over-reliance on AI, and differences in how patients respond. These are managed through clinical oversight and system validation.
How can I use AISN technologies safely?
Always discuss AI-supported recommendations with your healthcare professional and ask questions if anything is unclear.